Rs.97.90for 1 strip(s) (10 tablets each)
food interaction for RIVAFord Tablet
alcohol interaction for RIVAFord Tablet
pregnancy interaction for RIVAFord Tablet
lactation interaction for RIVAFord Tablet
food
alcohol
pregnancy
lactation
RIVAFord 10mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
None
None
CAUTION
Caution is advised when consuming alcohol with RIVAFord 10mg Tablet. Please consult your doctor.
CAUTION
RIVAFord 10mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
CONSULT YOUR DOCTOR
RIVAFord 10mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
CONSULT YOUR DOCTOR
SALT INFORMATION FOR RIVAFord 10mg Tablet
Rivaroxaban(10mg)
Rivaford tablet uses
{med_name} is used for blood clots. It prevents the formation of blood clots in the legs, lungs, brain or heart.
How rivaford tablet works
RIVAFord 10mg Tablet is a novel oral anticoagulant (NOAC). It works by stopping a clotting factor called factor Xa from working. This helps prevent the formation of blood clots in the body.
Common side effects of rivaford tablet
Bleeding
SUBSTITUTES FOR RIVAFord Tablet
76 Substitutes
76 Substitutes
Sorted By
Rs. 261.70pay 91% more per Tablet
Rs. 951.56pay 1248% more per Tablet
Rs. 234.30pay 55% more per Tablet
Rs. 280.31pay 178% more per Tablet
Rs. 206.20pay 104% more per Tablet
Expert advice FOR RIVAFord Tablet
- For best results, take Rivaroxaban at the same time every day. It is better to take at night with meals.
- It interacts less with food or other medicines. Hence, frequent dose changes are not required.
- It increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails, using sharp objects or engaging in contact sports (e.g. football, wrestling).
- It may cause dizziness. Avoid driving or activity requiring mental focus until you know how it affects you.
- If you are going to have a surgery or dental treatment, you may be asked to stop taking Rivaroxaban temporarily.
- Notify your doctor if you have any kidney problem.
- Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.
- Do not stop taking medication without talking to your doctor.
Frequently asked questions FOR RIVAFord 10mg Tablet
Rivaroxaban
Q. What are the side effects of RIVAFord 10mg Tablet?
The most common side effects of RIVAFord 10mg Tablet include long or excessive bleeding, breathlessness (which may be a sign of bleeding), exceptional weakness, tiredness, paleness, dizziness, headache, and unexplained swelling. Other side effects can be severe skin and allergic reactions, bruising, coughing up blood, bleeding from the skin or under the skin, and swelling and pain in the limbs. Using RIVAFord 10mg Tablet may increase the bilirubin and decrease the number of platelets. Some people may experience fainting episodes, faster heartbeat, and dry mouth. In case you notice any side effects, immediately contact your doctor.
Q. Is RIVAFord 10mg Tablet a blood thinner?
Yes, RIVAFord 10mg Tablet is a blood thinner. It is a medication that prevents the blood from clotting within the blood vessels. It also prevents the blood clots from recurring in the blood vessels. It may be prescribed to treat blood clots in the veins of the legs and in the blood vessels of the lungs.
Q. Is RIVAFord 10mg Tablet dangerous?
RIVAFord 10mg Tablet has numerous beneficial effects, but it has a tendency to make you bleed more than normal come even with minor injuries as it reduces your blood’s clotting ability. Sometimes RIVAFord 10mg Tablet may cause serious bleeding which may be dangerous and may need urgent medical attention. This risk may be higher in people taking RIVAFord 10mg Tablet along with other blood thinning medications. Contact your doctor if you notice even minor bleeding.










